12-52544684-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_033448.3(KRT71):c.1420G>A(p.Gly474Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000093 in 1,613,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_033448.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT71 | NM_033448.3 | c.1420G>A | p.Gly474Ser | missense_variant | 9/9 | ENST00000267119.6 | NP_258259.1 | |
KRT71 | XM_047428197.1 | c.1294G>A | p.Gly432Ser | missense_variant | 8/8 | XP_047284153.1 | ||
KRT71 | XM_017018749.2 | c.1174G>A | p.Gly392Ser | missense_variant | 10/10 | XP_016874238.1 | ||
KRT71 | XM_047428196.1 | c.1030-335G>A | intron_variant | XP_047284152.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT71 | ENST00000267119.6 | c.1420G>A | p.Gly474Ser | missense_variant | 9/9 | 1 | NM_033448.3 | ENSP00000267119 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152180Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000639 AC: 16AN: 250512Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135538
GnomAD4 exome AF: 0.0000787 AC: 115AN: 1461462Hom.: 0 Cov.: 57 AF XY: 0.0000729 AC XY: 53AN XY: 727058
GnomAD4 genome AF: 0.000230 AC: 35AN: 152180Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74318
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 474 of the KRT71 protein (p.Gly474Ser). This variant is present in population databases (rs149479435, gnomAD 0.07%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with KRT71-related conditions. ClinVar contains an entry for this variant (Variation ID: 2254138). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 07, 2022 | The c.1420G>A (p.G474S) alteration is located in exon 9 (coding exon 9) of the KRT71 gene. This alteration results from a G to A substitution at nucleotide position 1420, causing the glycine (G) at amino acid position 474 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at